Wulf Blankenfeldt

6.6k citations
147 papers · 4.9k indexed · h-index 38

Wulf Blankenfeldt

144 papers receiving 4.9k citations

Peers

Wulf Blankenfeldt
Comparison fields: 5 of 136
  • Endocrinology 411
  • Molecular Medicine 292
  • Molecular Biology 3.1k
  • Pharmacology 755
  • Cell Biology 590
Replace Tzu‐Ping Ko with:
Tzu‐Ping Ko Taiwan
Shih‐Hsiung Wu Taiwan
Nam‐Chul Ha South Korea
Wim J. Quax Netherlands
David L. Ollis Australia
Min Yao Japan
Changjiang Dong United Kingdom
Satish K. Nair United States
Andrew M. Gulick United States
Maarten R. Egmond Netherlands
Wulf Blankenfeldt relative to Tzu‐Ping Ko Taiwan Tzu‐Ping Ko's profile →
Citations per field
00.5×3.1×
Tzu‐Ping Ko · 1×
Citations per year

Countries citing papers authored by Wulf Blankenfeldt

Since Specialization
Citations

This map shows the geographic impact of Wulf Blankenfeldt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wulf Blankenfeldt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wulf Blankenfeldt more than expected).

Fields of papers citing papers by Wulf Blankenfeldt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wulf Blankenfeldt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wulf Blankenfeldt. The network helps show where Wulf Blankenfeldt may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Wulf Blankenfeldt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wulf Blankenfeldt Line = papers co-authored together Wulf Blankenfeldt links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20251
3 20250
4 20251
5 20242
6 20241
7 20240
8 20241
9 20245
10 20241
11 202318
12 20232
13 20224
14 202241
15 202113
16 20212
17 202111
18 20203
19 201722
20 2010283

About Wulf Blankenfeldt

Wulf Blankenfeldt is a scholar working on Molecular Medicine, Endocrinology and Pharmacology, having authored 147 papers that have together received 4.9k indexed citations. Recurring topics across this work include Enzyme Structure and Function (37 papers), Microbial Natural Products and Biosynthesis (23 papers), Bacterial Genetics and Biotechnology (20 papers), Biochemical and Molecular Research (17 papers), Bacterial biofilms and quorum sensing (15 papers), Antibiotic Resistance in Bacteria (13 papers), Protein Structure and Dynamics (11 papers) and Peptidase Inhibition and Analysis (11 papers). The work is most often cited by research in Endocrinology (411 citations), Molecular Medicine (292 citations) and Molecular Biology (3.1k citations). Wulf Blankenfeldt has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Dmitri V. Mavrodi, Linda S. Thomashow, Roger S. Goody, Aymelt Itzen, Rolf Breinbauer, Florian P. Seebeck, Stefan Schoebel, Nikolaus Guttenberger, Julia Blümer and Matthias Müller. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026